Target Name: LOC105369165
NCBI ID: G105369165
Review Report on LOC105369165 Target / Biomarker Content of Review Report on LOC105369165 Target / Biomarker
LOC105369165
Other Name(s): Uncharacterized LOC105369165 | uncharacterized LOC105369165

LOC105369165: A Potential Drug Target and Biomarker

LOC105369165 is a gene that has not yet been assigned a specific function, but it is known to encode a protein with potential drug targets and biomarker properties. The protein encoded by this gene has been shown to have unique features that may make it an attractive target for drug development. This article will explore the potential drug target and biomarker properties of LOC105369165 and its potential in the pharmaceutical industry.

Potential Drug Target

The protein encoded by LOC105369165 is known to have unique features that may make it an attractive target for drug development. One of its defining features is its novelty. Unlike many proteins, LOC105369165 does not have a well-known sequence or structure. This lack of information makes it difficult to predict its function, but it also allows for the possibility of new functions to be discovered.

Another feature that may make LOC105369165 an attractive drug target is its expression level. It has been shown to be highly expressed in various tissues and organs, which suggests that it may be involved in a variety of physiological processes. This may make it an attractive target for drugs that target various cellular processes.

In addition, LOC105369165 has also been shown to interact with a variety of different proteins. This interaction may suggest that it plays a role in the regulation of various cellular processes and functions. This interaction may also indicate potential drug targets for diseases that are characterized by the over-regulation or under-regulation of cellular processes.

Potential Biomarker

LOC105369165 has also been shown to have potential as a biomarker for a variety of diseases. One of the most promising applications for this gene is its potential to serve as a biomarker for cancer. Cancer is a leading cause of death worldwide, and there is a need for new and more effective treatments.

Studies have shown that LOC105369165 has been expressed in a variety of cancer tissues and that it has potential to serve as a biomarker for cancer. This suggests that it may be a useful tool for the development of new cancer therapies.

Another potential application for LOC105369165 is its potential as a biomarker for neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are characterized by the progressive loss of brain cells and can have a significant impact on an individual's quality of life.

Research has shown that LOC105369165 has been expressed in the brains of individuals with neurodegenerative diseases and that it may be a useful tool for the development of new therapies for these diseases.

Conclusion

LOC105369165 is a gene that has not yet been assigned a specific function, but it is known to encode a protein with potential drug targets and biomarker properties. The unique features of this protein, including its novelty and high expression level, make it an attractive target for drug development. Additionally, its potential as a biomarker for cancer and neurodegenerative diseases makes it a promising tool for the development of new therapies.

The future of LOC105369165 and its potential drug targets and biomarkers is bright. With further research, it is likely that we will discover new functions for this gene and its protein as a drug target and biomarker.

Protein Name: Uncharacterized LOC105369165

The "LOC105369165 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369165 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076